AstraZeneca plc (ADR) (AZN)
The Company discovers, develops, manufactures and markets prescription pharmaceuticals for important areas of healthcare: cancer, cardiovascular, gastrointestinal, infection, neuroscience, and respiratory and inflammation.
Recs
Looks like a recession stock, and we could be headed out of that sooner than later.
Recs
This is a great stock, it will gain with it working with other companies, but it will not out pace the S&P. This is going to be a steady stock with few huge gains.
Recs
Oncology is a major area for any pharmaceutical company. Arimidex is about to go off patent in the next two years and they have no other blockbusters that are far along in clinical trial development.
Recs
I like the MedImmune acquisition but their balance sheet looks like crap- 5billion in cash vs 15billion in debt, plus negative earnings and revenue. Think it will take some time before the MedImmune acquisition starts to pay off
Recs
Several state AG's; Arkansas for one, have joined in a class action lawsuit that may prove costly for AZN.
Recs
Recs
This stock is analogous to the titanic. Bad news when CFO leaves right after a big transaction with MedImmune.
Recs
They may need some Levitra as some of their drugs go off patent.
Recs
While AZN has made a smart deal with Palatin (PTN), I'm generally bearish on big pharma. Lots of legislation is going to come about that will cost them a lot of money.
Recs
The Democrats are coming! The Democrats are coming!
Recs
AstraZeneca halted development of two new drug candidates: Galida for diabetes and Exanta for blood clotting. Nexuim may face pressure from prilosec due to cost by insurance companies. Crestor is a good play.

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 11 of 11